Deng D, Zhao L, Song H, Wang H, Cao H, Cui H
Sci Rep. 2025; 15(1):7126.
PMID: 40021742
PMC: 11871317.
DOI: 10.1038/s41598-025-91626-4.
Chen S, Shen C, Zeng X, Sun L, Luo F, Wan R
Front Microbiol. 2025; 16:1515364.
PMID: 39959156
PMC: 11826063.
DOI: 10.3389/fmicb.2025.1515364.
Ugai S, Liu L, Kosumi K, Kawamura H, Hamada T, Mima K
Gut Microbes. 2025; 17(1):2452237.
PMID: 39937126
PMC: 11834522.
DOI: 10.1080/19490976.2025.2452237.
Leon-Gomez P, Romero V
Front Microbiol. 2025; 15:1515258.
PMID: 39911706
PMC: 11794528.
DOI: 10.3389/fmicb.2024.1515258.
Tozzi M, Fiore A, Travaglione S, Marcon F, Rainaldi G, Germinario E
J Exp Clin Cancer Res. 2025; 44(1):29.
PMID: 39876002
PMC: 11776187.
DOI: 10.1186/s13046-024-03271-w.
The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications.
Ding T, Liu C, Li Z
Mol Cancer. 2025; 24(1):18.
PMID: 39815314
PMC: 11734361.
DOI: 10.1186/s12943-025-02227-8.
Intratumor microbiota and colorectal cancer: Comprehensive and lucid review.
Zong Z, Zeng W, Li Y, Wang M, Cao Y, Cheng X
Chin J Cancer Res. 2025; 36(6):683-699.
PMID: 39802896
PMC: 11724182.
DOI: 10.21147/j.issn.1000-9604.2024.06.07.
Oat Beta-Glucans Modulate the Gut Microbiome, Barrier Function, and Immune Responses in an In Vivo Model of Early-Stage Colorectal Cancer.
Guzowska M, Dziendzikowska K, Kopiasz L, Gajewska M, Wilczak J, Harasym J
Int J Mol Sci. 2025; 25(24.
PMID: 39769349
PMC: 11677220.
DOI: 10.3390/ijms252413586.
Study of Microbiota Associated to Early Tumors Can Shed Light on Colon Carcinogenesis.
Aspesi A, La Vecchia M, Sala G, Ghelardi E, Dianzani I
Int J Mol Sci. 2025; 25(24.
PMID: 39769073
PMC: 11677268.
DOI: 10.3390/ijms252413308.
Factors underlying the association between , subspecies infection and colorectal cancer: a mini review.
Warner D, Mehta A
Gut Microbiome (Camb). 2024; 5:e9.
PMID: 39703539
PMC: 11658940.
DOI: 10.1017/gmb.2024.11.
New Insights into Mucosa-Associated Microbiota in Paired Tumor and Non-Tumor Adjacent Mucosal Tissues in Colorectal Cancer Patients.
Gonzalez A, Fullaondo A, Navarro D, Rodriguez J, Tirnauca C, Odriozola A
Cancers (Basel). 2024; 16(23).
PMID: 39682194
PMC: 11640486.
DOI: 10.3390/cancers16234008.
Systematic review: The gut microbiota as a link between colorectal cancer and obesity.
Ruiz-Malagon A, Rodriguez-Sojo M, Redondo E, Rodriguez-Cabezas M, Galvez J, Rodriguez-Nogales A
Obes Rev. 2024; 26(4):e13872.
PMID: 39614602
PMC: 11884970.
DOI: 10.1111/obr.13872.
Oral Microbial Changes in Oral Squamous Cell Carcinoma: Focus on , , and .
Lee Y, Jung J, Hong J
Medicina (Kaunas). 2024; 60(11).
PMID: 39596938
PMC: 11596053.
DOI: 10.3390/medicina60111753.
Delineating the nexus between gut-intratumoral microbiome and osteo-immune system in bone metastases.
Kapoor S, Gupta M, Sapra L, Kaur T, Srivastava R
Bone Rep. 2024; 23:101809.
PMID: 39497943
PMC: 11532283.
DOI: 10.1016/j.bonr.2024.101809.
Exploring the gut microbiome's role in colorectal cancer: diagnostic and prognostic implications.
Chen G, Ren Q, Zhong Z, Li Q, Huang Z, Zhang C
Front Immunol. 2024; 15:1431747.
PMID: 39483461
PMC: 11524876.
DOI: 10.3389/fimmu.2024.1431747.
Genetics, diet, microbiota, and metabolome: partners in crime for colon carcinogenesis.
La Vecchia M, Sala G, Sculco M, Aspesi A, Dianzani I
Clin Exp Med. 2024; 24(1):248.
PMID: 39470880
PMC: 11522171.
DOI: 10.1007/s10238-024-01505-x.
Parvimonas micra forms a distinct bacterial network with oral pathobionts in colorectal cancer patients.
Lowenmark T, Kohn L, Kellgren T, Rosenbaum W, Bronnec V, Lofgren-Burstrom A
J Transl Med. 2024; 22(1):947.
PMID: 39420333
PMC: 11487773.
DOI: 10.1186/s12967-024-05720-8.
Escherichia coli on colorectal cancer: A two-edged sword.
Jian C, Yinhang W, Jing Z, Zhanbo Q, Zefeng W, Shuwen H
Microb Biotechnol. 2024; 17(10):e70029.
PMID: 39400440
PMC: 11472651.
DOI: 10.1111/1751-7915.70029.
Effects of intratumoral microbiota on tumorigenesis, anti-tumor immunity, and microbe-based cancer therapy.
Zheng J, Chen H
Front Oncol. 2024; 14:1429722.
PMID: 39391251
PMC: 11464362.
DOI: 10.3389/fonc.2024.1429722.
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy.
Li Q, Geng S, Luo H, Wang W, Mo Y, Luo Q
Signal Transduct Target Ther. 2024; 9(1):266.
PMID: 39370455
PMC: 11456611.
DOI: 10.1038/s41392-024-01953-7.